Add like
Add dislike
Add to saved papers

Longitudinal Study of Peripapillary Thinning in Sickle Cell Hemoglobinopathies.

PURPOSE: To determine the rate of retinal nerve fiber layer (RNFL) thinning in patients with sickle cell hemoglobinopathies. Design; Prospective cohort study METHODS: Sixty-seven patients averaging 35.8±11.5 years old at enrollment with electrophoretically-confirmed sickle cell hemoglobinopathies followed by the University of Illinois at Chicago retina clinic for ≥1 year were included. Exclusion criteria included a history of diabetes, uncontrolled hypertension, glaucoma, ocular opacities, other retinopathies, and previous retinal procedures. The optic nerve head retinal nerve fiber layer thicknesses were measured with Spectral-domain optical coherence tomography (Heidelberg Spectralis, Heidelberg Engineering, Inc, Carlsbad, CA, USA) at enrollment and subsequent follow-ups. Linear mixed models were used to estimate rates of thinning.

RESULTS: A total of 122 eyes were followed for 3.8±2.0 years (range 1 to 8 years). Mean global peripapillary RNFL thickness was 100.9±13.0 μm at baseline. Global peripapillary RNFL thickness decreased at a rate of 0.98 (95% confidence intervals (CI) 0.77 to 1.19) μm/year. A history of stroke was associated with a faster rate of global RNFL thinning (1.72±0.20 vs. 0.79±0.12 μm/year, P <0.001), whereas a history of hypertension was associated with a slower rate of thinning (0.33±0.27 vs. 1.14±0.12 μm/year, P = 0.002).

CONCLUSIONS: Peripapillary RNFL thinning in patients with sickle cell hemoglobinopathies occurred faster in patients with a history of stroke and slower in those with controlled hypertension. Future studies will compare these rates to those of healthy age- and race-matched individuals.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app